Bert Klebl

USPTO Granted Patents = 6 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 9.7

ph-index = 4

Forward Citations = 88(Granted Patents)

Location History:

Oberschweinbad, DE (2011)
Dortmund, DE (2013 - 2021)

Company Filing History:

5 out of 14

Lead Discovery Center Gmbh

patents

3 out of 1,289

Max-planck-gesellschaft Zur Förderung Der Wissenschaften E. V.

patents

1 out of 378

Bayer Pharma Aktiengesellschaft

patents

4. 1 out of 721

Bayer Intellectual Property Gmbh

patents

5. 1 out of 6

Ingenium Pharmaceuticals Gmbh

where one patent can have more than one assignee

Years Active: 2011-2021

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11111238 - Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2021-09-07),

2. 10703735 - 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2020-07-07),

3. 9242937 - Pharmaceutically active disubstituted pyridine derivatives (2016-01-26),

4. 8999982 - Pharmaceutically active compounds as Axl inhibitors (2015-04-07),

5. 8507498 - 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases (2013-08-13),

6. 8084457 - Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases (2011-12-27),

Title: The Innovative Journey of Bert Klebl

Introduction: Bert Klebl, a pioneering inventor hailing from Dortmund, Germany, has made significant contributions to the world of innovation through his groundbreaking work in various fields.

Latest Patents: Bert Klebl's latest patents showcase his commitment to pushing the boundaries of technology and science, with a focus on advancements in biotechnology and pharmaceuticals.

Career Highlights: With a distinguished career spanning several decades, Bert Klebl has held key positions in research institutions and biotech companies, leading teams to develop cutting-edge solutions for complex challenges.

Collaborations: Throughout his career, Bert Klebl has collaborated with top researchers, scientists, and industry experts to drive forward innovative projects that have the potential to revolutionize the way we approach healthcare and biotechnology.

Conclusion: Bert Klebl's unwavering dedication to innovation and his relentless pursuit of scientific excellence continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.